NAUT · 10-Q · 2026Q1 · Full report

Distribution Channels and Sales Buildout

Nautilus Biotechnology, Inc. · 2026-04-28 · Importance 31 · Surprise 42

Nautilus plans to commercialize the Voyager platform through a direct sales channel in the United States and through both direct and distributor channels outside the U.S. The company is in the early stages of building commercial, service and support capabilities and made its first sales hire during the three months ended March 31, 2026. Management intends to build sales, marketing and distribution infrastructure across the United States, European Union, the United Kingdom and potentially Asia-Pacific to support the phased commercial launch. Given current development stage, Nautilus acknowledges its marketing and distribution capabilities are limited and will require material investment to scale.

Key facts

• Nautilus made its first sales hire during the three months ended March 31, 2026.
• Nautilus expects initial customer access to the Nautilus Voyager platform to be through its Early Access Program in which Nautilus will perform analysis and profiling of samples in its facility and share results via a cloud platform.
• Nautilus intends to commercialize the Nautilus Voyager platform through a direct sales channel in the United States and through both direct and distributor sales channels in regions outside the United States.
• Nautilus intends to build sales, marketing, service and distribution infrastructure in the United States, the European Union, the United Kingdom, and potentially Asia-Pacific.

Impact estimates